TFTamara Viktorovna Fedotkina

Tamara Viktorovna Fedotkina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tamara Viktorovna Fedotkina has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Potential molecular mimicry of proteins involved in atherogenesis and/or vasculitides with coronavirus antigens

    by Leonid P. Churilov, Victor S. Gurevich, Maria V. Muzalevskaya, Tatiana A. Novitskaya, Valeriia A. Shapkina, Polina A. Sobolevskaia, Vladimir J. Utekhin, Tamara V. Fedotkina, Muslimbek G. Normatov

    Aim: This study explores the pathogenesis of atherosclerosis, as well as the comorbidity of atherosclerosis and coronavirus infection. The objective of the article is to provide a rationale for the potential involvement of an autoimmune component in the observed comorbidity between these two conditions. Methods: The research utilized bioinformatic and laboratory techniques. The bioinformatic approach involved selecting 30 human autoantigens, either proven or hypothesized to participate in atherogenesis and/or arteritides, as well as the most immunogenic proteins from human coronavirus antigens. To identify shared minimal immunogenic determinants (pentapeptides) between human autoantigens and coronavirus antigens, the proprietary “Alignmentaj” program was employed. Antibody levels against apolipoprotein B-100 (ApoB-100) and Proteinase 3 (PR3) were measured using enzyme-linked immunosorbent assay (ELISA) in patients with cardiovascular disease following coronavirus disease 2019 (COVID-19). Post-mortem tissue samples were subjected to standard morphological examination, supplemented with immunohistochemical methods for pathomorphological analysis. Results: The analysis revealed that the spike protein of human coronaviruses exhibits the highest concentration of pentapeptides similar to those found in atherogenesis-associated proteins. Notably, ApoB-100 shared the greatest number of peptides. Post-COVID cardiovascular patients showed varied anti-ApoB antibody and anti-PR3 antibody levels and potential complications. Pathomorphological examination of the aorta and coronary arteries of patients who died from atherothrombotic complications following COVID-19 infection revealed signs of autoimmune inflammation. Lymphocytic infiltration, consisting of T-cells and B-cells, as well as indications of vasa vasorum vasculitis, were observed in areas of unstable aortic atherosclerotic plaques and in the adventitia of coronary arteries. Conclusions: The identified sequence homology between human coronavirus antigens and human autoantigens, together with laboratory data obtained from patients with cardiovascular pathology following COVID-19, supports the hypothesis that molecular mimicry contributes to the initiation or exacerbation of atherosclerotic cardiovascular disease in the post-COVID period.

  • Open Access

    Immunological Mechanisms and Machine Learning Applications in Post-COVID-19 Syndrome: A Narrative Review

    by Leonid P. Churilov, Anna Starshinova, Igor Kudryavtsev, Artem Rubinstein, Olesya Koroteeva, Anastasia Kulpina, Varvara A. Ryabkova, Adilya Sabirova, Polina Sobolevskaia, Tamara Fedotkina, et al.

    Post-COVID-19 syndrome (PCS), also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), represents a heterogeneous set of persistent clinical manifestations developing after acute infection. These conditions are associated with immune dysregulation, autonomic imbalance, impaired thymic function, and possible viral persistence. Objective: This study aims to systematically synthesise current evidence on the immunopathogenesis of PCS and to critically evaluate the application of artificial intelligence (AI) and machine learning (ML) approaches for its prediction and clinical stratification. Methods: A PRISMA 2020–informed systematic review was conducted using PubMed/MEDLINE, Scopus, Web of Science, elibrary.ru and Embase databases (January 2020–December 2025). Studies addressing immunopathological mechanisms and AI/ML applications in PCS were selected based on predefined eligibility criteria. Risk of bias in prediction studies was assessed using the PROBAST tool. Due to heterogeneity, a structured qualitative synthesis was performed. Current evidence indicates that PCS may result from sustained systemic inflammation, cytokine dysregulation, autoimmunity, and delayed restoration of T-cell homeostasis, including reduced thymic output of naïve T lymphocytes. Persistent thymic dysfunction may contribute to prolonged immune imbalance, increased susceptibility to secondary infections, and reactivation of latent viruses. AI/ML approaches—including gradient boosting, ensemble learning, deep neural networks, and natural language processing—have demonstrated promising performance across multimodal datasets. However, significant limitations were identified, including small sample sizes, overfitting, lack of external validation, and heterogeneity in outcome definitions. Conclusions: The integration of immunopathological insights with data-driven modelling highlights the potential of combined approaches for improving PCS risk stratification. However, current AI models remain insufficiently validated for clinical implementation. Future research should prioritise methodological standardisation, external validation, and incorporation of mechanistically informed biomarkers.


  • Open Access

    Immunological Disorders: Gradations and the Current Approach in Laboratory Diagnostics

    by Anna A. Starshinova, Andrey An. Savchenko, Alexander Borisov, Igor Kudryavtsev, Artem Rubinstein, Irina Dovgalyuk, Anastasia Kulpina, Leonid P. Churilov, Polina Sobolevskaia, Tamara Fedotkina, et al.

    Currently, understanding the immune response, its abnormalities, and its diagnostic possibilities is a key point in the management of patients with various diseases, from infectious to oncological ones. The aim of this review was to analyze the data presented in the current literature on immune disorders and the possibility of their laboratory diagnostics in combination with clinical manifestations. We have performed a systematic analysis of the literature presented in international databases over the last ten years. We have presented data on the possibility of diagnosing immunopathological processes due to changes in immune cells and soluble molecules involved in the pathogenesis of a wide range of diseases, as well as the determination of antibodies to detect autoimmune processes. By applying laboratory techniques such as hematology, flow cytometry, ELISA, etc., available to most clinical laboratories worldwide, clinical data on immune system dysfunction in a wide range of diseases are being collected. This process is unfortunately still very far from being completed. However, with all the diversity of accumulated knowledge, we can currently state that the pathogenesis of the vast majority of immune-mediated diseases is not yet known. At the same time, the current success in dividing immune-mediated diseases into distinct clusters based on different types of inflammatory responses that are based on the involvement of different populations of T helper cells and cytokine molecules represents significant progress. Further research in this direction seems very promising, as it allows the identification of new target cells and target molecules for both improved diagnostics and targeted therapies.


  • Open Access

    A complicated form of spontaneous aortic atherosclerosis in an African green monkeys (Chlorocebus aethiops sabaeus) male. Clinical case

    by Sergey Orlov, Andrey Panchenko, Viktor Shestakov, Artem Oganesian, Yulia Kolesnik, David Ilyazyants, Elena Radomskaya, Tamara Fedotkina, Dmitry Bulgin, Leonid Churilov

    Atherosclerosis is the mechanistic basis of cardiovascular disorders manifested by damage to the walls of the aorta, coronary, cerebral and peripheral arteries, leading to the development of acute or chronic ischemia of internal organs and tissues. This publication describes a case of spontaneous atherosclerotic lesion of the aorta with the formation of a dissecting aneurysm in an African green monkey male. The ancestors were introduced from Ethiopia and Europe. The case monkey was housed as a family group in an outdoor enclosure with attached smaller room equipped with heating system. It lived 16.4 years. Pathological diagnosis was established through complete autopsy and histopathology. Main disease was chronic atrophic gastroenterocolitis in exacerbation complicated with alimentary dystrophy, cachexia (brown atrophy of the myocardium, liver, skeletal muscles). The concomitant diseases: complicated atherosclerosis of the aorta, dissecting abdominal aortic aneurysm with a large cylindrical organized thrombus in the aneurysm area, stenosing atherosclerosis of the renal arteries, vascular wrinkled left kidney; focal atherosclerosis of the coronary arteries and their branches with small foci of atherosclerotic cardiosclerosis and arteriosclerosis of cerebral arteries. The revealed changes indicate a significant similarity in the pathomorphogenesis of atherosclerotic lesions in African green monkey and humans. It allows us to consider this genus of primates as a promising laboratory model for studying the pathogenesis and mechanisms of regression as well as the effectiveness of therapeutic approaches to the treatment of atherosclerosis and its complications.


  • Open Access

    Autoantigens of Nervous System and Human Coronavirus Antigens: Is There a Possibility for Molecular Mimicry?

    by Natalia Y. Gavrilova, Muslimbek G. Normatov, Lidia A. Soprun, Vladimir J. Utekhin, Tamara V. Fedotkina, Leonid P. Churilov

    In post-COVID-19 syndrome, clinical presentation of the nerve fiber dysfunction plays an important role. The possibility of autoantigen cross-mimicry of coronavirus infection and the peripheral nervous system need to be investigated. The bioinformatic analysis was applied to search for possible common protein sequences located in the immunological epitopes. Among the autoantigens of the human nervous system, fibroblast growth factor receptor protein 3, myelin protein P0, myelin protein P2, sodium channel protein type 9, alpha protein subunit, plexin-D1 protein and ubiquitin-carboxyl-terminal hydrolase protein of the L1 isoenzyme were selected. The “Alignmentaj” program was created. The UniProt database, Protein Data Bank and AlphaFold databases were used. The analysis of protein sequence similarities of spike glycoproteins in human coronaviruses revealed common pentapeptides of the MERS-CoV-2 virus with the fibroblast growth factor receptor 3 and myelin protein P2. Among seasonal coronaviruses, common peptide sequences were identified in HCoV-HKU-1 virus with sodium channel protein type 9 subunit alpha and Plexin-D1, HCoV-OС43 with Plexin-D1, as well as HCoV-NL63 with Plexin-D1 and Ubiquitin carboxyl-terminal hydrolase isozyme L1. The data obtained make it possible to identify new potential targets for the development of autoimmune reactions that occur against the background of the activity of highly pathogenic and seasonal coronaviruses.

  • TRADITIONAL AND MODERN VISUALIZATION METHODS IN TEACHING HISTOLOGY

    by Sivukhina E.V., Konovalova S.G., Fedotkina T.V., Shamray E.A., Shuyskaya S.V., Shuyskiy L.S.


  • Open Access

    Assessment of Hearing and Vestibular Functions in a Post-COVID-19 Patient: A Clinical Case Study

    by Irina Germanovna Andreeva, Alisa Gvozdeva, Vera Pimenova, Varvara Ryabkova, Maria Lukashenko, Evelina Kamaeva, Valeria Shapkina, Lidia Soprun, Natalia Gavrilova, Tamara Viktorovna Fedotkina, et al.

    SARS-CoV-2 infection may cause such complications as post-COVID-19 syndrome, which includes chronic fatigue, myalgia, arthralgia, as well as a variety of neurological manifestations, e.g., neuropathy of small fibers, hearing and vestibular dysfunction, and cognitive impairment. This clinical case describes a 41-year-old patient suffering from post-COVID-19 syndrome and chronic fatigue syndrome. A detailed examination was performed, including an in-depth study of peripheral and central hearing and vestibular functions, as well as small nerve fibers length and density in the skin and cornea of the eye. Contrary to expectations, no peripheral nervous system dysfunction was detected, despite the presence of dizziness and gait instability in the patient. Hearing tests (gap detection test and dichotic test) showed central auditory processing disorders. The evaluated lesion in the processing of temporal and verbal auditory information can be a significant factor contributing to additional overload of the neural activity and leading to chronic fatigue when performing daily activities in patients with CFS and post-COVID-19 complications.


  • Open Access

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground?

    by Varvara A. Ryabkova, Natalia Y. Gavrilova, Tamara V. Fedotkina, Leonid P. Churilov, Yehuda Shoenfeld

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease of unknown etiology, sharing a similar clinical presentation with the increasingly recognized post-COVID syndrome. We performed the first cross-sectional study of ME/CFS in a community population in Russia. Then we described and compared some clinical and pathophysiological characteristics of ME/CFS and post-COVID syndrome as neuroimmune disorders. Of the cohort of 76 individuals who suggested themselves as suffering from ME/CFS, 56 were diagnosed with ME/CFS by clinicians according to ≥1 of the four most commonly used case definitions. Of the cohort of 14 individuals with post-COVID-19 syndrome, 14 met the diagnostic criteria for ME/CFS. The severity of anxiety/depressive symptoms did not correlate with the severity of fatigue either in ME/CFS or in post-COVID ME/CFS. Still, a positive correlation was found between the severity of fatigue and 20 other symptoms of ME/CFS related to the domains of “post-exertional exhaustion”, “immune dysfunction”, “sleep disturbances”, “dysfunction of the autonomic nervous system”, “neurological sensory/motor disorders” and “pain syndromes”. Immunological abnormalities were identified in 12/12 patients with ME/CFS according to the results of laboratory testing. The prevalence of postural orthostatic tachycardia assessed in the active orthostatic test amounted to 37.5% in ME/CFS and 75.0% in post-COVID ME/CFS (the latter was higher than in healthy controls, p = 0.02). There was a more pronounced increase in heart rate starting from the 6th minute of the test in post-COVID ME/CFS compared with the control group. Assessment of the functional characteristics of microcirculation by laser doppler flowmetry revealed obvious and very similar changes in ME/CFS and post-COVID ME/CFS compared to the healthy controls. The identified laser doppler flowmetry pattern corresponded to the hyperemic form of microcirculation disorders usually observed in acute inflammatory response or in case of systemic vasoconstriction failure.


  • Open Access

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground?

    by Varvara A. Ryabkova, Natalia Y Gavrilova, Tamara V Fedotkina, Leonid P Churilov, Yehuda Shoenfeld

    A Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease of unknown aetiology under growing interest now in view of the increasingly recognized post-COVID syndrome as a new entity with similar clinical presentation. We performed the first cross-sectional study of ME/CFS in community population in Russia and then described and compared some clinical and pathophysiological characteristics of ME/CFS and post-COVID syndrome as neuroimmune disorders. Of the cohort of 76 individuals who suggested themselves suffering from ME/CFS 56 subsequently were confirmed as having CFS/ME according to ≥1 of the 4 most commonly used case definition. Of the cohort of 14 individuals with post-COVID-19 syndrome 14 met diagnostic criteria for ME/CFS. The prevalence of clinically expressed and subclinical anxiety and depression in ME / CFS and post-COVID ME/CFS did not differ significantly from that in healthy individuals. Severity of anxiety / depressive symptoms did not correlate with the severity of fatigue neigther in ME / CFS nor in post-COVID ME/CFS, but the positive correlation was found between the severity of fatigue and 20 other symptoms of ME / CFS related to the domains of “post-exertional exhaustion”, “immune dysfunction”, “sleep disturbances”, "dysfunction of the autonomic nervous system", "neurological sensory / motor disorders" and "pain syndromes". Immunological abnormalities were identified in 12/12 patients with ME / CFS according to the results of laboratory testing. The prevalence of postural orthostatic tachycardia assessed by the active standing test was 37.5% in ME / CFS and 75.0% in post-COVID ME/CFS (the latter was higher than in healthy controls, p = 0.02) There was a more pronounced increase in heart rate starting from the 6th minute of the test in post-COVID ME/CFS compared with the control group. Assessment of the functional characteristics of microcirculation by laser doppler flowmetry revealed obvious and very similar changes in ME/CFS and post-COVID ME/CFS compared to the healthy controls. The identified pattern corresponded to the hyperemic form of microcirculation disorders, usually observed in acute inflammatory processes or in deficiency of systemic vasoconstriction influences.


  • Open Access

    New Clinical Phenotype of the Post-Covid Syndrome: Fibromyalgia and Joint Hypermobility Condition

    by Natalia Gavrilova, Lidiia Soprun, Maria Lukashenko, Varvara Ryabkova, Tamara V. Fedotkina, Leonid P. Churilov, Yehuda Shoenfeld

    Fibromyalgia can be defined as a chronic pain condition, affecting the musculoskeletal system, etiology and pathophysiology of which is sufficiently understudied. Despite the fact that many authors consider this entity to be a manifestation of central sensitization, and not an autoimmune disease, the high prevalence of fibromyalgia in patients with post-COVID-19 conditions requires taking a fresh look at the causes of the disease development. During the patient examination, the authors identified a combination of symptoms that occurs so often, that they can be carefully described as a clinical pattern. These manifestations include young age, female gender, joint hypermobility, the onset of pain after COVID-19, physical traumatization of one particular tendon and the development of the fibromyalgia pain syndrome during the next several weeks. As well as an increase in the titer of antinuclear antibodies and some other systemic inflammation factors. It can be assumed with great caution that local damage to the connective tissue in patients with joint hypermobility, having COVID-19 as a trigger factor can lead to the development of fibromyalgia syndrome. This article presents three clinical cases that illustrated this hypothesis.